Nigorin 30 mg (Nisergoline)

Adult dose

* 5 mg, 10 mg Adults: Administer 5 ∼ 10 mg of nicergoline orally 2 ∼ 3 times daily before meals. Adjust the dose as appropriate according to symptoms. * 30 mg Adults: Administer 30 mg of nicergoline orally once daily before a meal. If the desired effect is not achieved at this dose, it may be increased to 60 mg. The dose may be reduced after symptoms improve. Reduce the dose in patients with impaired renal function (serum creatinine >175 µmol/L) (2 mg/dL).

This drug should not be used in patients with hypersensitivity to ergot alkaloids. It is safe not to administer it to patients with acute myocardial infarction or acute hemorrhage. It is advised not to use this drug in patients taking sympathomimetic agents, patients with very slow heart rates, patients who have not completed hemostasis after intracranial hemorrhage, and patients with orthostatic dysregulation. Caution is required when administering to patients with mild bradycardia or renal dysfunction, and should be taken according to the doctor's instructions. When taking this medication, gastrointestinal symptoms such as loss of appetite, diarrhea, constipation, nausea, vomiting, abdominal pain, and dry mouth may rarely occur. Due to possible elevated liver function test results, it is necessary to regularly check liver health. Symptoms such as dizziness, orthostatic hypotension, blood pressure changes, and increased blood uric acid levels may occur, so inform medical personnel immediately if symptoms arise. Symptoms of neurological abnormalities such as drowsiness, fatigue, headache, tinnitus, and insomnia have also been reported rarely, so caution is necessary. Allergic reactions such as rash, hives, itching, flushing, and warmth may occur. When this drug is taken with other medications that lower blood pressure, its hypotensive effects may be potentiated, so blood pressure should be monitored frequently. Since it can affect uric acid metabolism, patients with a history of gout should use it with caution. Drowsiness or dizziness may occur after taking this drug, so caution is needed when driving or operating machinery. This drug is metabolized in the liver, so interactions with other medications may occur, so it is essential to inform your healthcare provider of any other medications being taken. Women who are pregnant or may become pregnant should consult a doctor, as the use of this drug may pose risks to the fetus. If breastfeeding, it is advisable to avoid taking this drug or to discontinue breastfeeding, as it may be secreted in breast milk. Elderly patients may require dose adjustments due to decreased bodily functions. Safety in pediatric patients has not been established, so it should be used cautiously in children. In cases of overdose, blood pressure may temporarily decrease, so if abnormal symptoms occur, visit a hospital immediately. This medication should be kept out of the reach of children and stored securely in its original container.

Loss of appetite, diarrhea, constipation, nausea, vomiting, localized upper abdominal pain or cramping, dry mouth, elevated ALT, elevated AST, dizziness, orthostatic hypotension, hypertension, increased blood uric acid, blood pressure drop, drowsiness, malaise, headache, tinnitus, fatigue, insomnia, rash, urticaria, itching, flushing, warmth sensation, nightmares, mood disturbances, dyspepsia

This medication should be stored in a tightly sealed container that blocks light, and kept at a temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's efficacy and prevent degradation.

Appearance

Yellow round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle